RecruitingNCT06356272

Oropharynx (OPX) Biomarker Trial


Sponsor

Mayo Clinic

Enrollment

560 participants

Start Date

Nov 15, 2019

Study Type

OBSERVATIONAL

Conditions

Summary

The purpose of this research is to identify a biomarker that is exists when human papillomavirus (HPV) mediated oropharyngeal squamous cell carcinoma is present and does not exist when HPV mediated oropharyngeal squamous cell carcinoma is absent.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study collects detailed biological information (biomarkers) from patients with cancers of the throat and mouth area — particularly oropharyngeal cancers related to HPV — to better understand how these tumors behave and how to predict who will respond well to treatment. **You may be eligible if...** - You are 18 or older and able to provide written consent - You have been diagnosed with, or are suspected to have, a cancer or abnormal growth in the head and neck area (including throat, mouth, thyroid, or salivary glands) - You are willing to have your tumor tissue, blood, and/or saliva samples used for research - You can complete questionnaires (alone or with help) **You may NOT be eligible if...** - You are currently enrolled in another cancer treatment trial - You have had another active cancer within the past 5 years (with some exceptions for early-stage or cured cancers) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERNon-Interventional Study

Non-interventional study


Locations(1)

Mayo Clinic in Rochester

Rochester, Minnesota, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06356272


Related Trials